Interim / Quarterly Report • Sep 1, 2023
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

Investor Presentation

August 2023

Building a Safer Future

Information in this presentation is based on the unaudited financial statements prepared in accordance with the new IFRS 9 and IFRS 17 standards effective from 1 January 2023. The data for the comparative periods were adjusted to reflect the implementation of the specified new standards from 1 January 2022 onwards. The data do not contain elimination of intercompany transactions.
The information, statements or data contained here in have been prepared by Triglav corporate officers. Zavarovalnica Triglav, d.d., or any member of Triglav Group, or any Zavarovalnica Triglav employee or representative accepts no responsibility for the information, statements or data contained herein or omitted here from, and will not be liable to any third party for any reason whatsoever relating to the information, statements or data contained herein or omitted here from. Such information, statements or data may not be prepared according to the same standards and requirements than the information, statements or data included in Triglav's own reports and press releases are prepared to, and accordingly the level of information and materiality and nature of the disclosures may be different. Undue reliance should not be placed on the information, statements or data contained herein because they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results to differ materially from those expressed or implied in such information, statements or data. Moreover, the information, statements and data contained herein have not been, and will not be, updated or supplemented with new or additional information, statements or data.
© Triglav Group: H1 2023 Results Investor Presentation


1


H1 2023 Highlights


5
Profitable and safe operations with growth in business volume. Positive investment returns. Loss in Health. Increased service expenses not yet fully offset with income growth. Financial stability and capitalisation at appropriate levels despite challenging economic situation.
Unexpected changes to Slovenian healthcare system In 2023 loss in Group's supplemental health insurance due to price regulation and other
| H1 2023 operations | |
|---|---|
| Unexpected changes to Slovenian healthcare system | In 2023 loss in Group's supplemental health insurance due to price regulation and other restrictions |
| Net CAT events In Q3 2023 (floods, hail) | Unprecedentedly high CAT claims in Slovenia and the region |
| in 2023 realised annual result around 80% lower than initially planned |
|
| Corporate governance | MB: In March 2023 Blaž Jakič began term of office as MB member representatives |
| Sustainable development | ESG framework upgraded with Sustainable Development Policy, Sustainable Investment Policy and PAI statement (in accordance with SFDR) |
2023 Outlook Due to changes to Slovenian healthcare system and unprecedented extreme weather events in 2023 realised annual result around 80% lower than initially planned
Dividend In 2023 In 2023 dividend paid of EUR 2.50 gross per share (51% dividend payout; 7% dividend yield)
MB: In March 2023 Blaž Jakič began term of office as MB member SB: Appointment Tim Umberger and Monica Cramer Manhem as SB members – shareholder
Sustainable development ESG framework upgraded with Sustainable Development Policy, Sustainable Investment Policy and PAI statement (in accordance with SFDR)

Up by 11% y-o-y €-3.7M in H1 2022 101.1% in H1 2022
| GWP | +12% | €893.5M |
|---|---|---|
| OTHER INCOME | -3% | €61.8M |
| Total | +11% | €955.4M |

investment returns due to favourable
▪ Impact of loss in Health due to changes in


6


| H1 2023 | H1 2022** | H1 2023/ H1 2022 |
Key performance indicators H1 2023 H1 2022 |
|---|---|---|---|
| 955.4 | 861.2 | 111 | ROE annualised 2.3% -0.8% |
| 893.5 | 797.2 | 112 | Claims ratio 78.8% 78.2% |
| 737.9 | 658.9 | 112 | Expense ratio 23.4% 22.9% |
| 19.9 | 24.0 | 83 | Combined ratio Non-life and Health 102.2% 101.1% |
| 53.8 | -72.6 | Combined ratio Non-life 97.0% 101.0% |
|
| -46.6 | 72.9 | CSM of new contracts/Total CSM 9.5% 11.5% |
|
| 214.4 | 188.8 | 114 | |
| 10.5 | -3.7 | ||
| 9.9 | -3.7 | ||
| 8.7 | -42.8 | ||
| 30 Jun 2023 | 31 Dec 2022 | 30 Jun 2023/ 31 Dec 2022 |
|
| 4,039.7 | 3,901.1 | 104 | |
| 856.2 | 894.3 | 96 | |
| 208.7 | 186.4 | 112 | **Under IFRS 17 and IFRS 9, last year's results are significantly lower than |
| 73.6 | 70.8 | 104 | under the previously applicable IFRS 4 and IAS 39, and this is mainly due to |
| 5,309 | 5,306 | 100 | differences in measurement of insurance technical provisions and recognition of effects of revaluation of financial investments. |
**Under IFRS 17 and IFRS 9, last year's results are significantly lower than under the previously applicable IFRS 4 and IAS 39, and this is mainly due to differences in measurement of insurance technical provisions and Last year's H1 result in accordance with IFRS 17 was negatively affected by prudential additional reserving due to sharp rise in inflation, whereas – unlike under IFRS 4 – result was not positively affected by effects of release of provisions from past periods.



H1 2023: Capitalisation at appropriate levels
Majority of capital is Tier 1 eligible. Capital management centralised at Group level (capital concentration at parent company)



H1 2023: Decrease in equity mainly result of dividend payment in 2023



H1 2023: No major changes compared to 2022 YE. Further increase of underwriting risk (higher volume of business and claims, also CAT), decrease of market risk, slightly increased credit risk (higher investments in cash). Risk regarding operations of Triglav health insurance company.


*Net of investment guarantees


H1 2023 PBT stemmed equally from insurance and non-insurance operations (mainly asset management). Insurance business under influence of solid investment result and negative result from underwriting activities due to loss in Health. Increased expenses and claims intensity due to inflation.


11

| Components | (in M€; growth y-o-y) |
|---|---|
| GWP (premium) | 893.5 (+12%) |
| Other Income |
61.8 (-3%) |
| Total | 955.4 (+11%) |
Strong GWP growth due to price increases and increased business volume. Decrease in Other income due to last year's realised one-off gains on disposal of real property.

Total Business Volume by Segments (in €M)
12
Gross Written Premium by Segments (in €M)




13

(estimated values; in €M)
Most frequent Triglav´s CAT loss events are flood, storm, hail and frost.

14

Extreme weather events in Slovenia and region, particularly storms, hailstorms and floods in July and August, resulted in historically high claims for Triglav Group. They are currently estimated at EUR 150–200 M. Taking into account reinsurance coverage, their negative impact on Group's PBT is estimated between EUR 40 and 50 M.
15
Gross Operating Expenses (in €M)

214.4
| Insurance Gross Operating Expenses |
(in M€; as at H1 2023; growth y-o-y) | ||
|---|---|---|---|
| Non – life |
150.5 | +15% | Insurance gross operating expenses increased |
| Life & Pensions | 30.7 | +6% | predominantly due to higher acquisition costs and labour costs |
| Health | 11.5 | +19% | |
| TOTAL: | 192.7 | +14% |

Insurance Gross Operating Expenses by Segments
16

H1 2023 CoR (102.2%) influenced by loss in Health. H1 2022 CoR (101.1%) impacted by last year's additional reserving due to sharp rise in inflation. Last year's adjustments of insurance premiums to inflation are reflected in this year's income but increased operating expenses due to inflationary pressures that have been present since early 2022 are still not fully offset.

© Triglav Group: H1 2023 Results Investor Presentation

| Return on financial investments¹ (in M€) |
H1 2023 |
H1 2022 |
|---|---|---|
| Interest income² | 16.5 | 11.9 |
| Dividend income | 0.5 | 0.3 |
| Net gains/losses on fin. assets at FVTPL |
3.1 | -9.9 |
| Net gains/losses on fin. assets at AC |
0 | 0 |
| Net gains/losses on fin. assets at FVOCI |
-1.6 | -2.8 |
| Net impairment/reversal of impairment of fin. assets |
1.6 | -2.3 |
| Other investment income/expenses | -3.6 | 1.5 |
| Total¹ | 16.5 | -1.2 |
| Total with United-linked life contracts |
53.8 | -72.6 |
Annualised return¹: 1.6% (in H1 2022: -0.1%)
¹ Unit-linked life insurance assets excluded
² Calculated using effective interest method
New Business Margin: 13.1% (up by 2.2 pp y-o-y)

Net Claims ratio Expense ratio




Total Contractual Service Margin (CSM) development (in €M) ▪ New CSM is confirmation of further profitability of
Contractual service margin (CSM) includes unearned profit that Company expects to earn from insurance contracts. It is calculated based on expected future cash flows (inflows and outflows), taking into account time value of money and risk adjustment.





| (in €M) | H1 2023 | H1 2022 | Index |
|---|---|---|---|
| Total business volume | 687.0 | 597.1 | 115 |
| Total revenue | 560.3 | 483.5 | 116 |
| Insurance contract revenue | 552.8 | 474.3 | 117 |
| - premium allocation approach (PAA) |
536.4 | 460.5 | 116 |
| - general model (BBA) |
16.4 | 13.8 | 119 |
| Insurance service expenses | 467.3 | 417.7 | 112 |
| - premium allocation approach (PAA) |
460.4 | 414.9 | 111 |
| - general model (BBA) |
6.9 | 2.9 | 243 |
| Result from reinsurance contracts | -46.3 | -39.4 | |
| Insurance contract result | 39.2 | 17.2 | 227 |
| Financial result from insurance contracts | -2.1 | -0.6 | |
| Investment result | 5.8 | -0.2 | |
| Operating expenses | 150.5 | 130.6 | 115 |
| Profit before tax | 23.2 | -5.1 | |
| Other comprehensive income | 5.8 | -37.4 | |
| Combined ratio | 97.0 % | 101.0 % | -4.0 p.p |
| CSM of new contracts/CSM | 22.2 % | 28.3 % | -6,1 p.p |
| Expenses to insurance revenue ratio | 27.2 % | 27.5 % | -0,3 p.p |
| 30 Jun 2023 | 31 Dec 2022 | Index | |
| Contractual service margin (CSM) | 15.7 | 16.2 | 97 |
| Risk adjustment (RA) | 41.5 | 41.0 | 101 |
| Net liabilities from insurance contracts | 996.5 | 886.4 | 112 |
| Net assets from reinsurance contracts | 320.2 | 261.1 | 123 |




| (in €M) | H1 2023 | H1 2022 | Index |
|---|---|---|---|
| Total business volume | 141.2 | 135.8 | 104 |
| Total revenue | 46.5 | 42.8 | 109 |
| Insurance contract revenue | 41.7 | 38.1 | 110 |
| - general model (BBA) |
27.5 | 25.6 | 107 |
| - variable fee approach (VFA) |
14.2 | 12.5 | 114 |
| - premium allocation approach (PAA) |
0.0 | 0.0 | 96 |
| Insurance service expenses | 31.6 | 31.1 | 102 |
| - general model (BBA) |
21.9 | 21.2 | 103 |
| - variable fee approach (VFA) |
9.7 | 9.9 | 98 |
| - premium allocation approach (PAA) |
0.0 | 0.0 | |
| Result from reinsurance contracts | 0.0 | 0.4 | -6 |
| Insurance contract result | 10.0 | 7.4 | 136 |
| Financial result from insurance | |||
| contracts | -44.4 | 73.4 | |
| Investment result | 47.0 | -66.8 | |
| Operating expenses | 30.7 | 28.8 | 106 |
| Profit before tax | 12.9 | -0.7 | |
| Other comprehensive income | 1.5 | -0.3 | |
| CSM of new contracts/CSM | 8.5% | 10.3% | - 1,8 p.p |
| New business margin | 13.1% | 10.9% | 2,2 p.p |
| Expenses to insurance revenue ratio | 73.6% | 75.7% | -2,2 p.p |
| 30 Jun 2023 | 31 Dec 2022 | Index | |
| Contractual service margin (CSM) | 192.9 | 170.1 | 113 |
| Risk adjustment (RA) | 28.2 | 26.1 | 108 |
| Net liabilities from insurance contracts | 1,276.1 | 1,233.4 | 103 |
| Net assets from reinsurance contracts | 0.1 | 7.9 | 1 |

Impact of announced termination of supplemental health insurance as part of reform of Slovenian healthcare system. Negative effects of price limitation of supplemental health insurance until 2023 YE reflected in immediate recognition of loss from supplemental health contracts. As a result, insurance service result of Health in H1 2023 €–29.3 M.

| H1 2023 | H1 2022 | Index | |
|---|---|---|---|
| Total business volume | 105.0 | 102.2 | 103 |
| Total revenue | 104.3 | 102.1 | 102 |
| Insurance contract revenue | 104.2 | 102.1 | 102 |
| - premium allocation approach (PAA) |
103.1 | 101.0 | 102 |
| - general model (BBA) |
1.1 | 1.1 | 102 |
| Insurance service expenses | 134.0 | 102.5 | 131 |
| - premium allocation approach (PAA) |
146.9 | 101.4 | 145 |
| - general model (BBA) |
-12.9 | 1.0 | |
| Result from reinsurance contracts | 0.5 | -0.2 | -308 |
| Insurance contract result | -29.3 | -0.6 | |
| Financial result from insurance contracts | -0.1 | 0.0 | |
| Investment result | -0.3 | 0.0 | |
| Operating expenses | 11.5 | 9.6 | 119 |
| Profit before tax | -30.9 | -1.7 | |
| Other comprehensive income | 1.0 | -5.1 | |
| Combined ratio | 129.5% | 101.7% | + 27,8 p.p |
| CSM of new contracts/CSM | 10.6% | 16.3% | - 5,7 p.p |
| Expenses to insurance revenue ratio | 11.0% | 9.4% | + 1,6 p.p |
| 30 Jun 2023 |
31 Dec 2022 | Index | |
| Contractual service margin (CSM) | 0.1 | 0.1 | 105 |
| Risk adjustment (RA) | 4.0 | 3.7 | 106 |
| Net liabilities from insurance contracts | 54.0 | 43.6 | 124 |
| Net assets from reinsurance contracts | 1.2 | 0.6 | 185 |

Insurance portfolios, Unit-linked portfolios and Assets from financial contracts
22
| Instruments (in €M) |
Index | ||
|---|---|---|---|
| 30 Jun 2023 | 31 Dec 2022 | 2023/2022 | |
| Investment property | 68.0 | 68.3 | 99 |
| Investments in associates | 39.2 | 37.8 | 104 |
| Shares and other variable-income securities | 185.2 | 199.8 | 93 |
| Debt and other fixed-income securities | 1,790.6 | 1,801.7 | 99 |
| Loans given | 6.9 | 6.6 | 105 |
| Bank deposits | 78.6 | 79.5 | 99 |
| Other financial instruments | 1.6 | 1.6 | 103 |
| Total (1) | 2,170.1 | 2,195.4 | 99 |
| Unit-linked life insurance contract investments (2) | 520.1 | 469.5 | 111 |
| Financial investments from financial contracts (3) | 619.0 | 589.0 | 105 |
| Total (1+2+3) | 3,309.2 | 3,253.9 | 102 |


Asset Allocation
(assets from united-linked products and financial contracts excluded)

¹Assets from unit-linked products and financial contracts excluded







As at H1 2023: We estimate that due to two external factors, i.e. changes to Slovenian healthcare system and CAT claims, and assuming normal claims development until the end of 2023, our profit this year will be around 80% lower than planned (initially plan of EUR 95 - 110 M).
Explanation of external factors that influence the realization of 2023 plan:
25
Dividend Policy






9.1% Market Share
(-0.5 pp y-o-y)
8.1% 4th rank Market Share (Q1 2023) 5th rank
13.4%
Market Share
(-2.5 pp y-o-y)
3rd rank


21.7% (+0.1 pp y-o-y)
1 st rank





Minimum dividend pay-out is set to 50% of consolidated net profit for previous year. Triglav will strive not to reduce its dividend payment below level of previous year. Dividend policy is subordinated to achieving medium-term sustainable target capital adequacy of Triglav Group.
Three objectives are followed in balanced manner: to ensure prudent capital management of Triglav Group and its financial stability, to reinvest net profit in implementation of strategy of growth and development of Triglav Group and to pay out attractive dividends to shareholders.
0
0,5
1
1,5
2
2,5
3
3,5

4
In 2020: Regulator's call upon insurance companies in Slovenia to suspend payout of dividends. In 2021: Triglav met regulator's requirements for dividend payment related to uncertainties in markets due to pandemic. In 2022: Several aspects and circumstances of recent years also taken into account.
Investor Relations Department Helena Ulaga Kitek, Director of IR Email: [email protected] Website: www.triglav.eu

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.